Abstract
Purpose
The purpose of the present study is to explore the influence of body mass index (BMI) on outcomes of in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) techniques in Chinese women with polycystic ovary syndrome (PCOS).
Methods
This was a multicenter, prospective, observational study that enrolled 800 subjects with PCOS from nine hospitals in China. Patients were categorized according to BMI categories: underweight, <18.5 kg/m2; normal, 19–23.9 kg/m2; overweight, 24–27.9 kg/m2; and obese, ≥28 kg/m2. Total recombinant follicle-stimulating hormone (rFSH) dose used, estradiol, and progesterone levels on human chorionic gonadotropin (hCG) day; implantation rate; and biochemical, clinical, and ongoing pregnancy rates were compared among BMI categories. Hormone levels (estradiol, follicle-stimulating hormone (FSH), LH, testosterone, and progesterone) were measured using electrochemiluminescence assays.
Results
Among the 774 subjects, 27.3 % were overweight and 8.1 % were obese. The rFSH dose used differed significantly among BMI categories (P < 0.001). The implantation rate was lower in obese subjects than that in normal-weight subjects (25.3 vs 45.7 %). Clinical pregnancy rate per transfer differed among BMI categories (P = 0.033), but there was no difference for biochemical (P = 0.327) and ongoing (P = 0.084) pregnancy rates. The miscarriage rate was similar among BMI categories.
Conclusions
More than one third of Chinese women with PCOS undergoing IVF/ICSI are overweight or obese. Elevated BMI is associated with reduced clinical pregnancy rate but similar ongoing pregnancy rates, suggesting that BMI has little impact on IVF outcomes.
Similar content being viewed by others
References
Franks S. Polycystic ovary syndrome. N Engl J Med. 1995;333(13):853–61. doi:10.1056/NEJM199509283331307.
Al-Azemi M, Omu FE, Omu AE. The effect of obesity on the outcome of infertility management in women with polycystic ovary syndrome. Arch Gynecol Obstet. 2004;270(4):205–10. doi:10.1007/s00404-003-0537-2.
Nugent D, Vandekerckhove P, Hughes E, Arnot M, Lilford R. Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome. Cochrane Database Syst Rev. 2000;4:CD000410. doi:10.1002/14651858.CD000410.
Levi Setti PE. The importance of consistent FSH delivery in infertility treatment. Reprod Biomed Online. 2006;12(4):493–9.
Sneed ML, Uhler ML, Grotjan HE, Rapisarda JJ, Lederer KJ, Beltsos AN. Body mass index: impact on IVF success appears age-related. Hum Reprod. 2008;23(8):1835–9. doi:10.1093/humrep/den188.
Expert Consultation WHO. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157–63. doi:10.1016/S0140-6736(03)15268-3.
Szilagyi A, Homoki J, Bellyei S, Szabo I. Hormonal and clinical effects of chronic gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome. Gynecol Endocrinol. 2000;14(5):337–41.
Imani B, Eijkemans MJ, Faessen GH, Bouchard P, Giudice LC, Fauser BC. Prediction of the individual follicle-stimulating hormone threshold for gonadotropin induction of ovulation in normogonadotropic anovulatory infertility: an approach to increase safety and efficiency. Fertil Steril. 2002;77(1):83–90.
Bureau. MoHDC. Chinese adult overweight and obese prevention and control guideline (on trial). 2002.
He W, Li Q, Yang M, Jiao J, Ma X, Zhou Y, et al. Lower BMI cutoffs to define overweight and obesity in China. Obesity. 2015;23(3):684–91. doi:10.1002/oby.20995.
Oakkar EE, Stevens J, Truesdale KP, Cai J. BMI and all-cause mortality among Chinese and Caucasians: the People’s Republic of China and the Atherosclerosis Risk in Communities Studies. Asia Pac J Clin Nutr. 2015;24(3):472–9. doi:10.6133/apjcn.2015.24.3.12.
Rich-Edwards JW, Spiegelman D, Garland M, Hertzmark E, Hunter DJ, Colditz GA, et al. Physical activity, body mass index, and ovulatory disorder infertility. Epidemiology. 2002;13(2):184–90.
Costa Justus JF, Ligocki Campos AC, Figueroa AL, Gomis R, Santo MA, Favero GM, et al. Early effect of bariatric surgery on the circadian rhythms of adipokines in morbidly obese women. Metab Syndr Relat Disord. 2015. doi:10.1089/met.2015.0051.
Fedorcsak P, Dale PO, Storeng R, Ertzeid G, Bjercke S, Oldereid N, et al. Impact of overweight and underweight on assisted reproduction treatment. Hum Reprod. 2004;19(11):2523–8. doi:10.1093/humrep/deh485.
Pasquali R, Pelusi C, Genghini S, Cacciari M, Gambineri A. Obesity and reproductive disorders in women. Hum Reprod Update. 2003;9(4):359–72.
Caillon H, Freour T, Bach-Ngohou K, Colombel A, Denis MG, Barriere P, et al. Effects of female increased body mass index on in vitro fertilization cycles outcome. Obes Res Clin Pract. 2015;9(4):382–8. doi:10.1016/j.orcp.2015.02.009.
Chen H, Wang WJ, Chen YZ, Mai MQ, Ouyang NY, Chen JH, et al. Effects of body mass index and age on the treatment of in vitro fertilization-embryo transfer among patients with non-polycystic ovarian syndrome. Zhonghua Liu Xing Bing Xue Za Zhi. 2010;31(5):567–71.
Dokras A, Baredziak L, Blaine J, Syrop C, VanVoorhis BJ, Sparks A. Obstetric outcomes after in vitro fertilization in obese and morbidly obese women. Obstet Gynecol. 2006;108(1):61–9. doi:10.1097/01.AOG.0000219768.08249.b6.
Lashen H, Ledger W, Bernal AL, Barlow D. Extremes of body mass do not adversely affect the outcome of superovulation and in-vitro fertilization. Hum Reprod. 1999;14(3):712–5.
Shah DK, Missmer SA, Berry KF, Racowsky C, Ginsburg ES. Effect of obesity on oocyte and embryo quality in women undergoing in vitro fertilization. Obstet Gynecol. 2011;118(1):63–70. doi:10.1097/AOG.0b013e31821fd360.
Spandorfer SD, Kump L, Goldschlag D, Brodkin T, Davis OK, Rosenwaks Z. Obesity and in vitro fertilization: negative influences on outcome. J Reprod Med. 2004;49(12):973–7.
Bu Z, Dai W, Guo Y, Su Y, Zhai J, Sun Y. Overweight and obesity adversely affect outcomes of assisted reproductive technologies in polycystic ovary syndrome patients. Int J Clin Exp Med. 2013;6(10):991–5.
Huang K, Liao X, Dong X, Zhang H. Effect of overweight/obesity on IVF-ET outcomes in Chinese patients with polycystic ovary syndrome. Int J Clin Exp Med. 2014;7(12):5872–6.
Dechaud H, Anahory T, Reyftmann L, Loup V, Hamamah S, Hedon B. Obesity does not adversely affect results in patients who are undergoing in vitro fertilization and embryo transfer. Eur J Obstet Gynecol Reprod Biol. 2006;127(1):88–93. doi:10.1016/j.ejogrb.2005.12.009.
Fedorcsak P, Dale PO, Storeng R, Tanbo T, Abyholm T. The impact of obesity and insulin resistance on the outcome of IVF or ICSI in women with polycystic ovarian syndrome. Hum Reprod. 2001;16(6):1086–91.
Maheshwari A, Stofberg L, Bhattacharya S. Effect of overweight and obesity on assisted reproductive technology—a systematic review. Hum Reprod Update. 2007;13(5):433–44. doi:10.1093/humupd/dmm017.
Ozekinci M, Seven A, Olgan S, Sakinci M, Keskin U, Akar ME, et al. Does obesity have detrimental effects on IVF treatment outcomes? BMC Womens Health. 2015;15:61. doi:10.1186/s12905-015-0223-0.
Singh N, Gupta P, Mittal S, Malhotra N. Correlation of body mass index with outcome of in vitro fertilization in a developing country. Arch Gynecol Obstet. 2012;285(1):259–63. doi:10.1007/s00404-011-2013-8.
Zander-Fox DL, Henshaw R, Hamilton H, Lane M. Does obesity really matter? The impact of BMI on embryo quality and pregnancy outcomes after IVF in women aged ≤38 years. Aust N Z J Obstet Gynaecol. 2012;52(3):270–6. doi:10.1111/j.1479-828X.2012.01453.x.
Zhang D, Zhu Y, Gao H, Zhou B, Zhang R, Wang T, et al. Overweight and obesity negatively affect the outcomes of ovarian stimulation and in vitro fertilisation: a cohort study of 2628 Chinese women. Gynecol Endocrinol. 2010;26(5):325–32. doi:10.3109/09513591003632100.
Bellver J, Ayllon Y, Ferrando M, Melo M, Goyri E, Pellicer A, et al. Female obesity impairs in vitro fertilization outcome without affecting embryo quality. Fertil Steril. 2010;93(2):447–54. doi:10.1016/j.fertnstert.2008.12.032.
Vilarino FL, Christofolini DM, Rodrigues D, de Souza AM, Christofolini J, Bianco B, et al. Body mass index and fertility: is there a correlation with human reproduction outcomes? Gynecol Endocrinol. 2011;27(4):232–6.
Sathya A, Balasubramanyam S, Gupta S, Verma T. Effect of body mass index on in vitro fertilization outcomes in women. J Hum Reprod Sci. 2010;3(3):135–8. doi:10.4103/0974-1208.74155.
Schliep KC, Mumford SL, Ahrens KA, Hotaling JM, Carrell DT, Link M, et al. Effect of male and female body mass index on pregnancy and live birth success after in vitro fertilization. Fertil Steril. 2015;103(2):388–95. doi:10.1016/j.fertnstert.2014.10.048.
Vilarino FL, Bianco B, Christofolini DM, Barbosa CP. Impact of body mass index on in vitro fertilization outcomes. Rev Bras Ginecol Obstet. 2010;32(11):536–40.
Vural F, Vural B, Cakiroglu Y. The role of overweight and obesity in in vitro fertilization outcomes of poor ovarian responders. Biomed Res Int. 2015;2015:781543. doi:10.1155/2015/781543.
Zhang JJ, Feret M, Chang L, Yang M, Merhi Z. Obesity adversely impacts the number and maturity of oocytes in conventional IVF not in minimal stimulation IVF. Gynecol Endocrinol. 2015;31(5):409–13. doi:10.3109/09513590.2015.1014785.
Marquard KL, Stephens SM, Jungheim ES, Ratts VS, Odem RR, Lanzendorf S, et al. Polycystic ovary syndrome and maternal obesity affect oocyte size in in vitro fertilization/intracytoplasmic sperm injection cycles. Fertil Steril. 2011;95(6):2146–9. doi:10.1016/j.fertnstert.2010.10.026. 9 e1.
Metwally M, Cutting R, Tipton A, Skull J, Ledger WL, Li TC. Effect of increased body mass index on oocyte and embryo quality in IVF patients. Reprod Biomed Online. 2007;15(5):532–8.
Robker RL. Evidence that obesity alters the quality of oocytes and embryos. Pathophysiology. 2008;15(2):115–21. doi:10.1016/j.pathophys.2008.04.004.
Provost MP, Acharya KS, Acharya CR, Yeh JS, Steward RG, Eaton JL, et al. Pregnancy outcomes decline with increasing body mass index: analysis of 239,127 fresh autologous in vitro fertilization cycles from the 2008–2010 Society for Assisted Reproductive Technology registry. Fertil Steril. 2015. doi:10.1016/j.fertnstert.2015.11.008.
Moragianni VA, Jones SM, Ryley DA. The effect of body mass index on the outcomes of first assisted reproductive technology cycles. Fertil Steril. 2012;98(1):102–8. doi:10.1016/j.fertnstert.2012.04.004.
Coyne K, Whigham LD, O’Leary K, Yaklic JK, Maxwell RA, Lindheim SR. Gestational carrier BMI and reproductive, fetal and neonatal outcomes: are the risks the same with increasing obesity? Int J Obes. 2015. doi:10.1038/ijo.2015.159.
Jungheim ES, Lanzendorf SE, Odem RR, Moley KH, Chang AS, Ratts VS. Morbid obesity is associated with lower clinical pregnancy rates after in vitro fertilization in women with polycystic ovary syndrome. Fertil Steril. 2009;92(1):256–61. doi:10.1016/j.fertnstert.2008.04.063.
Kupka MS, Gnoth C, Buehler K, Dahncke W, Kruessel JS. Impact of female and male obesity on IVF/ICSI: results of 700,000 ART-cycles in Germany. Gynecol Endocrinol. 2011;27(3):144–9. doi:10.3109/09513590.2010.487617.
Petanovski Z, Dimitrov G, Ajdin B, Hadzi-Lega M, Sotirovska V, Matevski V, et al. Impact of body mass index (BMI) and age on the outcome of the IVF process. Prilozi. 2011;32(1):155–71.
Han AR, Kim HO, Cha SW, Park CW, Kim JY, Yang KM, et al. Adverse pregnancy outcomes with assisted reproductive technology in non-obese women with polycystic ovary syndrome: a case–control study. Clin Exp Reprod Med. 2011;38(2):103–8. doi:10.5653/cerm.2011.38.2.103.
Legge A, Bouzayen R, Hamilton L, Young D. The impact of maternal body mass index on in vitro fertilization outcomes. J Obstet Gynaecol Can. 2014;36(7):613–9.
Fedorcsak P, Storeng R, Dale PO, Tanbo T, Abyholm T. Obesity is a risk factor for early pregnancy loss after IVF or ICSI. Acta Obstet Gynecol Scand. 2000;79(1):43–8.
Metwally M, Ong KJ, Ledger WL, Li TC. Does high body mass index increase the risk of miscarriage after spontaneous and assisted conception? A meta-analysis of the evidence. Fertil Steril. 2008;90(3):714–26. doi:10.1016/j.fertnstert.2007.07.1290.
Krizanovska K, Ulcova-Gallova Z, Bouse V, Rokyta Z. Obesity and reproductive disorders. Sb Lek. 2002;103(4):517–26.
van Swieten EC, van der Leeuw-Harmsen L, Badings EA, van der Linden PJ. Obesity and clomiphene challenge test as predictors of outcome of in vitro fertilization and intracytoplasmic sperm injection. Gynecol Obstet Investig. 2005;59(4):220–4. doi:10.1159/000084347.
Qiao J, Lu G, Zhang HW, Chen H, Ma C, Olofsson JI, et al. A randomized controlled trial of the GnRH antagonist ganirelix in Chinese normal responders: high efficacy and pregnancy rates. Gynecol Endocrinol. 2012;28(10):800–4. doi:10.3109/09513590.2012.665103.
Acknowledgments
This study was supported by Merck Serono Co., Ltd. (Grant number EMR700623-530). We thank Wenfeng Chen (principal biostatistician) from Global Biostatistics & Epidemiology, Merck Serono (Beijing) Pharmaceutical R&D Co., Ltd. In addition, we thank all the staffs from research centers for their assistance.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
The study was approved by the ethics committees of the participating hospitals.
Informed consent
All study subjects were fully informed as to the nature of the study and provided written consent for inclusion.
Additional information
Capsule Elevated body mass index is associated with reduced clinical pregnancy rate but similar ongoing pregnancy rates.
Rights and permissions
About this article
Cite this article
Sheng, Y., Lu, G., Liu, J. et al. Effect of body mass index on the outcomes of controlled ovarian hyperstimulation in Chinese women with polycystic ovary syndrome: a multicenter, prospective, observational study. J Assist Reprod Genet 34, 61–70 (2017). https://doi.org/10.1007/s10815-016-0830-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-016-0830-1